Correlation between thyroid dysfunction and efficacy of immune checkpoint inhibitors in patients with advanced solid tumors
Abstract Background Immune checkpoint inhibitors (ICIs) are currently the first line of tumor immunotherapy for the treatment of a wide range of tumors. However, the main side effect of immune checkpoint inhibitors is that they cause immune-related adverse events (irAEs) in patients. The relationshi...
| Published in: | Discover Oncology |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-11-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01546-4 |